Here is What We Know About the Rollout of the Johnson & Johnson Vaccine.

#masthead-section-label, #masthead-bar-one { display: none }The Coronavirus OutbreakliveLatest UpdatesMaps and CasesRisk Near YouVaccine RolloutNew Variants TrackerAdvertisementContinue reading the main storyCovid-19: The U.S. Is Edging Toward Normal, Alarming Some OfficialsHere is what we know about the rollout of the Johnson & Johnson vaccine.March 1, 2021, 5:00 p.m. ETMarch 1, 2021, 5:00 p.m. ETJohnson & Johnson said it would start shipping millions of doses early this week after the Food and Drug Administration granted emergency use authorization for its vaccine on Saturday.CreditCredit…Pool photo by Timothy D. EasleyWhen Johnson & Johnson’s coronavirus vaccine won emergency use authorization on Saturday from the Food and Drug Administration, the move augmented the nation’s vaccination effort with a third major tool — one that differs markedly from the first two authorized vaccines, made by Pfizer-BioNTech and Moderna.Most notably, it is administered in a single dose instead of two, and can be kept unfrozen in an ordinary refrigerator for up to three months — features that promise greater flexibility as public health officials try to immunize Americans as quickly as possible.Much is still to be determined about how this new tool will be used. Here is what we know so far.When will people start getting the new vaccine?Within the next few days. Johnson & Johnson started shipping out doses on Monday, and they can be used as soon as they reach vaccination sites starting on Tuesday.Will adding the new supply speed up vaccination efforts?At first, the increase in availability will be limited. The company had about 3.9 million doses on hand to ship right away, but after that, deliveries could be patchy for a few weeks. (For comparison, the nation is using up that many doses of the Pfizer-BioNTech and Moderna vaccines in a little more than two days.)By the end of March, Johnson & Johnson says it will ship roughly 16 million more doses. Even so, the Pfizer-BioNTech and Moderna vaccines will continue to make up the majority of the nation’s supply.How is the new vaccine being allocated?The same way the two earlier vaccines are: in proportion to each state or territory’s population.Who will get the new vaccine?That’s still under discussion. The Centers for Disease Control and Prevention has said that the vaccine can be given to people 18 and over, and state officials are working out what their policies will be.Because the new vaccine is given in a single shot and doesn’t require cold storage, some experts and officials have suggested directing it toward hard-to-reach segments of the population (like rural residents or homeless people), or to people who might not keep an appointment for a second shot (like college students or those with mobility issues).But there is concern about appearing to favor or disfavor some groups, and the Biden administration has said it will insist that the new vaccine be distributed equitably.Will I be able to choose which vaccine I receive?That’s not clear. Right now, people are getting whichever vaccine the site has on hand when their turn comes, and appointment scheduling systems generally don’t tell users beforehand which it will be. Depending on how states decide to deploy the Johnson & Johnson vaccine, though, it may be possible to effectively choose what you get by choosing where you sign up to get it.Which vaccine should I prefer?Health experts say the best shot is the one you can get the soonest, whichever one it turns out to be. All three authorized vaccines are highly protective, and the differences among them pale in comparison, they say, with the risk you would run by being picky and passing up a chance to get a shot because it was not your top choice.How the Johnson & Johnson Vaccine WorksAn adenovirus helps prime the immune system to fight the coronavirus.AdvertisementContinue reading the main story

Read more →

How Johnson & Johnson's Vaccine Differs From Pfizer and Moderna's

AdvertisementContinue reading the main storyCovid-19: The U.S. Is Edging Toward Normal, Alarming Some OfficialsHere is how Johnson & Johnson’s vaccine differs from Pfizer’s and Moderna’s.Feb. 28, 2021, 2:21 p.m. ETFeb. 28, 2021, 2:21 p.m. ETThe vaccines already in wide use in the United States are given in two doses several weeks apart, while the newly authorized Johnson & Johnson vaccine is given in a single dose.Credit…Pool photo by Timothy D EasleyLeer en españolA third effective weapon was added to America’s arsenal against the coronavirus on Saturday when the Food and Drug Administration granted emergency use authorization for a vaccine developed by Johnson & Johnson.The company said it would start shipping millions of doses early this week, and would provide the United States with 100 million doses by the end of June. Together with 600 million doses of the nation’s first two authorized vaccines, made by Pfizer-BioNTech and Moderna, that are due to be delivered over the next four months, that ought to be enough to cover every American adult who wants to be vaccinated.The new vaccine differs markedly from the two already in use in the United States. Here is how they compare.One shot instead of twoThe Johnson & Johnson vaccine is administered in a single shot, while the Pfizer-BioNTech and Moderna vaccines are given in two shots several weeks apart.The way it worksThe Johnson & Johnson vaccine uses a different method to prime the body to fight off Covid-19: a viral vector called Ad26. Viral vectors are common viruses that have been genetically altered so that they do not cause illness but can still cause the immune system to build up its defenses. The Pfizer-BioNTech and Moderna vaccines use messenger RNA to do that.How well it worksThe Johnson & Johnson vaccine is rated as highly effective at preventing serious illness and death, as the Pfizer-BioNTech and Moderna vaccines are. It is also very effective at preventing milder illness, though a bit less so than those two. It appears to do well against the highly contagious B.1.351 variant, first identified in South Africa, that has given at least one other vaccine candidate trouble.Storage and handlingThe Johnson & Johnson vaccine does not have to be stored at extremely low temperatures like the Pfizer-BioNTech vaccine. It can safely be kept in an ordinary refrigerator for three months, much longer than the Moderna vaccine, which spoils after a month if not kept frozen.Side effectsThe Johnson & Johnson vaccine appears to be less prone than the Pfizer-BioNTech and Moderna vaccines to trigger the kinds of side effects that require monitoring after the injection, which may make it more suitable for use at drive-through vaccination sites. There have been reports that side effects tend to be felt more strongly after second doses, which the Johnson & Johnson vaccine does not require.AdvertisementContinue reading the main story

Read more →